Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorChulalongkorn University
About this trial
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.
Eligibility criteria
Qualifiers
Male or female age more than 18 years
No Diabetis mellitus disease and no taking diabetes medication
Blood sugar level less than 126 mg/dl and HbA1C less than 6.5
Can using Thai language
Disqualifiers
Allergic to mulberry extract
Take mulberry extract in 2 weeks before participate in this study
Take medications that have effect on blood sugar level such as steroid in 2 weeks before participate in this study
Have uncontrolled disease
Trial design
Treatments tested in this trial
- Mulberry Leaf Extract
- Placebo
Treatment groups
48 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov